Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Sezary Syndrome 1Sarcoma, Synovial 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Liposarcoma, Myxoid 1Leukemia, Myeloid, Acute 1HIV Infections 1Colorectal Neoplasms 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Trabectedin 3Radiation Dose Hypofractionation 3Cyclophosphamide 3fludarabine 2ribociclib 1pembrolizumab 1interferon gamma-1b 1cytochrome C synthetase 1brostallicin 1atezolizumab 1Sirolimus 1Pioglitazone 1Interferon-gamma 1Diathermy 1Dexamethasone 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Liposarcoma, Myxoid × interferon gamma-1b × Clear all
NCT03063632 2023-10-25

Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed
28 enrolled 15 charts
LymphoidSarcoma

Mycosis Fungoides, Sezary Syndrome, Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡